Mylan and Sanofi both seek summary judgment in EpiPen suit

EpiPen maker Mylan and Sanofi-Aventis, which used to make a competing device, have made opposing bids for summary judgment in Sanofi’s antitrust lawsuit against Mylan.

Get unlimited access to all Global Competition Review content